CIK: 0001381843 · Show all filings
Period: Q4 2024 (← Previous) (Next →)
Filing Date: Feb 4, 2025
Total Value ($000): $210,842 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| LLY | ELI LILLY & CO | 37,068 | $28,685 | 13.6% | $699.44 | +17.4% | COM | 532457108 |
| UNH | UNITEDHEALTH GROUP INC | 35,202 | $17,876 | 8.5% | $502.95 | +9.9% | COM | 91324P102 |
| ABBV | ABBVIE INC | 90,723 | $15,985 | 7.6% | $165.02 | +7.5% | COM | 00287Y109 |
| BSX | BOSTON SCIENTIFIC CORP | 154,222 | $13,831 | 6.6% | $68.73 | +28.1% | COM | 101137107 |
| TMO | THERMO FISHER SCIENTIFIC INC | 24,896 | $12,917 | 6.1% | $526.93 | +3.9% | COM | 883556102 |
| MRK | MERCK & CO INC | 105,727 | $10,400 | 4.9% | $108.20 | -8.8% | COM | 58933Y105 |
| SYK | STRYKER CORPORATION | 25,660 | $9,296 | 4.4% | $307.25 | +19.2% | COM | 863667101 |
| NBIX | NEUROCRINE BIOSCIENCES INC | 67,763 | $9,288 | 4.4% | $133.32 | -7.2% | COM | 64125C109 |
| ALKS | ALKERMES PLC | 266,499 | $7,670 | 3.6% | $26.35 | +9.1% | SHS | G01767105 |
| VRTX | VERTEX PHARMACEUTICALS INC | 22,257 | $7,596 | 3.6% | $416.73 | +11.2% | COM | 92532F100 |
| COR | CENCORA INC | 32,553 | $7,315 | 3.5% | $208.00 | +12.1% | COM | 03073E105 |
| AMGN | AMGEN INC | 27,414 | $7,108 | 3.4% | $267.21 | +7.1% | COM | 031162100 |
| — | INTRA-CELLULAR THERAPIES INC | 71,138 | $5,939 | 2.8% | $71.76 | — | COM | 46116X101 |
| EW | EDWARDS LIFESCIENCES CORP | 68,296 | $5,070 | 2.4% | $73.91 | -5.3% | COM | 28176E108 |
| MIRM | MIRUM PHARMACEUTICALS INC | 116,692 | $4,805 | 2.3% | $33.15 | +25.7% | COM | 604749101 |
| DXCM | DEXCOM INC | 60,057 | $4,684 | 2.2% | $99.35 | -25.5% | COM | 252131107 |
| HRMY | HARMONY BIOSCIENCES HLDGS IN | 120,501 | $4,104 | 1.9% | $33.61 | +2.2% | COM | 413197104 |
| CAH | CARDINAL HEALTH INC | 30,680 | $3,618 | 1.7% | $68.32 | +68.0% | COM | 14149Y108 |
| NAMS | NEWAMSTERDAM PHARMA COMPANY | 138,983 | $3,558 | 1.7% | $18.84 | +12.7% | ORDINARY SHARES | N62509109 |
| ACLX | ARCELLX INC | 42,071 | $3,296 | 1.6% | $59.65 | +44.8% | COMMON STOCK | 03940C100 |
| UFPT | UFP TECHNOLOGIES INC | 23,159 | $3,165 | 1.5% | $282.30 | +3.1% | COM | 902673102 |
| FOLD | AMICUS THERAPEUTICS INC | 326,840 | $3,076 | 1.5% | $11.55 | -10.0% | COM | 03152W109 |
| BBIO | BRIDGEBIO PHARMA INC | 103,032 | $2,815 | 1.3% | $27.97 | -7.6% | COM | 10806X102 |
| RVMD | REVOLUTION MEDICINES INC | 62,161 | $2,683 | 1.3% | $50.47 | 0.0% | COM | 76155X100 |
| — | MERUS N V | 62,521 | $2,619 | 1.2% | $40.60 | — | COM | N5749R100 |
| JANX | JANUX THERAPEUTICS INC | 39,573 | $2,078 | 1.0% | $52.89 | 0.0% | COM | 47103J105 |
| ONC | BEIGENE LTD | 10,900 | $2,004 | 1.0% | $183.81 | — | SPONSORED ADR | 07725L102 |
| KRYS | KRYSTAL BIOTECH INC | 9,202 | $1,470 | 0.7% | $130.58 | +35.9% | COM | 501147102 |
| MREO | MEREO BIOPHARMA GROUP PLC | 390,000 | $1,373 | 0.7% | $3.82 | — | SPON ADS | 589492107 |
| SMMT | SUMMIT THERAPEUTICS INC | 101,177 | $1,315 | 0.6% | $14.79 | +31.0% | COM | 86627T108 |
| CRBP | CORBUS PHARMACEUTICALS HLDGS | 98,304 | $1,188 | 0.6% | $30.77 | -45.5% | COM NEW | 21833P301 |
| AUTL | AUTOLUS THERAPEUTICS PLC | 479,644 | $1,060 | 0.5% | $4.04 | — | SPON ADS | 05280R100 |
| SLNO | SOLENO THERAPEUTICS INC | 30,940 | $985 | 0.5% | $48.45 | +6.9% | COM | 834203309 |
| — | MERSANA THERAPEUTICS INC | 538,621 | $765 | 0.4% | $2.39 | — | COM | 59045L106 |
| PHVS | PHARVARIS N V | 34,328 | $653 | 0.3% | $20.35 | +1.2% | COM | N69605108 |
| CABA | CABALETTA BIO INC | 247,454 | $554 | 0.3% | $8.81 | -60.1% | COM | 12674W109 |